Jeff Marrazzo, Spark CEO
February 23, 2022 10:30 AM ESTUpdated 02:37 PM
People
Cell/Gene Tx

With Spark safe­ly tucked in­to Roche, its found­ing CEO is off to search for new ad­ven­tures

Max Gelman

Senior Editor

Spark Ther­a­peu­tics made his­to­ry at the FDA by win­ning the first-ever ap­proval for a gene ther­a­py, when the agency green­light­ed Lux­tur­na in late 2017 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times